There was some evidence that there was a connection between genetic mimicry resulting from HMGCR inhibition and a greater risk of IBD and CD (ORIBD = 0.72, P = 0.0087; ORCD = 0.68, P = 0.018). Here, HMGCR is linked to inflammatory bowel disease.